Impact of Xpert MTB/RIF on Antiretroviral Therapy-Associated Tuberculosis and Mortality: A Pragmatic Randomized Controlled Trial.

Mupfumi, L; Makamure, B; Chirehwa, M; Sagonda, T; Zinyowera, S; Mason, P; Metcalfe, J Z; Mutetwa, R

Mupfumi, L; Makamure, B; Chirehwa, M; Sagonda, T; Zinyowera, S; Mason, P; Metcalfe, J Z; Mutetwa, R.

Afiliação

Mupfumi L; University of Zimbabwe College of Health Sciences , Harare , Zimbabwe ; Biomedical Research and Training Institute , Zimbabwe.
Makamure B; University of Zimbabwe College of Health Sciences , Harare , Zimbabwe ; Biomedical Research and Training Institute , Zimbabwe.
Chirehwa M; Biomedical Research and Training Institute , Zimbabwe.
Sagonda T; Biomedical Research and Training Institute , Zimbabwe.
Zinyowera S; National Microbiology Reference Laboratory , Harare , Zimbabwe.
Mason P; University of Zimbabwe College of Health Sciences , Harare , Zimbabwe ; Biomedical Research and Training Institute , Zimbabwe.
Metcalfe JZ; Division of Pulmonary and Critical Care Medicine , San Francisco General Hospital, and Francis J. Curry International Tuberculosis Center, University of California , San Francisco, California.
Mutetwa R; Biomedical Research and Training Institute , Zimbabwe.

Open Forum Infect Dis ; 1(1): ofu038, 2014 Mar.

Article em En | MEDLINE | ID: mdl-25734106

Palavras-chave

ART-associated TB; GeneXpert MTB/RIF; HIV; screening; tuberculosis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 3_ND / 4_TD Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Risk_factors_studies Idioma: En Revista: Open Forum Infect Dis Ano de publicação: 2014 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google